These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 25516843)
1. Identification of β-hematin inhibitors in a high-throughput screening effort reveals scaffolds with in vitro antimalarial activity. Sandlin RD; Fong KY; Wicht KJ; Carrell HM; Egan TJ; Wright DW Int J Parasitol Drugs Drug Resist; 2014 Dec; 4(3):316-25. PubMed ID: 25516843 [TBL] [Abstract][Full Text] [Related]
2. Heme Detoxification in the Malaria Parasite: A Target for Antimalarial Drug Development. de Villiers KA; Egan TJ Acc Chem Res; 2021 Jun; 54(11):2649-2659. PubMed ID: 33982570 [TBL] [Abstract][Full Text] [Related]
3. Use of the NP-40 detergent-mediated assay in discovery of inhibitors of beta-hematin crystallization. Sandlin RD; Carter MD; Lee PJ; Auschwitz JM; Leed SE; Johnson JD; Wright DW Antimicrob Agents Chemother; 2011 Jul; 55(7):3363-9. PubMed ID: 21518844 [TBL] [Abstract][Full Text] [Related]
4. Identification of β-hematin inhibitors in the MMV Malaria Box. Fong KY; Sandlin RD; Wright DW Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923 [TBL] [Abstract][Full Text] [Related]
5. Targeting the hemozoin synthesis pathway for new antimalarial drug discovery: technologies for in vitro beta-hematin formation assay. Tekwani BL; Walker LA Comb Chem High Throughput Screen; 2005 Feb; 8(1):63-79. PubMed ID: 15720198 [TBL] [Abstract][Full Text] [Related]
6. In vitro beta-hematin formation assays with plasma of mice infected with Plasmodium yoelii and other parasite preparations: comparative inhibition with quinoline and endoperoxide antimalarials. Tripathi AK; Gupta A; Garg SK; Tekwani BL Life Sci; 2001 Oct; 69(23):2725-33. PubMed ID: 11720077 [TBL] [Abstract][Full Text] [Related]
7. A colorimetric high-throughput beta-hematin inhibition screening assay for use in the search for antimalarial compounds. Ncokazi KK; Egan TJ Anal Biochem; 2005 Mar; 338(2):306-19. PubMed ID: 15745752 [TBL] [Abstract][Full Text] [Related]
8. Antimalarial drugs inhibiting hemozoin (beta-hematin) formation: a mechanistic update. Kumar S; Guha M; Choubey V; Maity P; Bandyopadhyay U Life Sci; 2007 Feb; 80(9):813-28. PubMed ID: 17157328 [TBL] [Abstract][Full Text] [Related]
9. Spectrophotometric determination of de novo hemozoin/beta-hematin formation in an in vitro assay. Tripathi AK; Khan SI; Walker LA; Tekwani BL Anal Biochem; 2004 Feb; 325(1):85-91. PubMed ID: 14715288 [TBL] [Abstract][Full Text] [Related]
10. High-Throughput Screening and Prediction Model Building for Novel Hemozoin Inhibitors Using Physicochemical Properties. Huy NT; Chi PL; Nagai J; Dang TN; Mbanefo EC; Ahmed AM; Long NP; Thoa LT; Hung LP; Titouna A; Kamei K; Ueda H; Hirayama K Antimicrob Agents Chemother; 2017 Feb; 61(2):. PubMed ID: 27919903 [TBL] [Abstract][Full Text] [Related]
11. The Effects of Quinoline and Non-Quinoline Inhibitors on the Kinetics of Lipid-Mediated β-Hematin Crystallization. Fitzroy SM; Gildenhuys J; Olivier T; Tshililo NO; Kuter D; de Villiers KA Langmuir; 2017 Aug; 33(30):7529-7537. PubMed ID: 28689414 [TBL] [Abstract][Full Text] [Related]
13. [Comparative observation on inhibition of hemozoin formation and their in vitro and in vivo anti-schistosome activity displayed by 7 antimalarial drugs]. Xue J; Jiang B; Liu CS; Sun J; Xiao SH Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2013 Jun; 31(3):161-9. PubMed ID: 24812850 [TBL] [Abstract][Full Text] [Related]
14. Adsorption to the Surface of Hemozoin Crystals: Structure-Based Design and Synthesis of Amino-Phenoxazine β-Hematin Inhibitors. Olivier T; Loots L; Kok M; de Villiers M; Reader J; Birkholtz LM; Arnott GE; de Villiers KA ChemMedChem; 2022 May; 17(10):e202200139. PubMed ID: 35385211 [TBL] [Abstract][Full Text] [Related]
15. Hemozoin inhibiting 2-phenylbenzimidazoles active against malaria parasites. L'abbate FP; Müller R; Openshaw R; Combrinck JM; de Villiers KA; Hunter R; Egan TJ Eur J Med Chem; 2018 Nov; 159():243-254. PubMed ID: 30296683 [TBL] [Abstract][Full Text] [Related]
16. Prediction Model for Antimalarial Activities of Hemozoin Inhibitors by Using Physicochemical Properties. Mosaddeque F; Mizukami S; Kamel MG; Teklemichael AA; Dat TV; Mizuta S; Toan DV; Ahmed AM; Vuong NL; Elhady MT; Giang HTN; Dang TN; Fukuda M; Huynh LK; Tanaka Y; Egan TJ; Kaneko O; Huy NT; Hirayama K Antimicrob Agents Chemother; 2018 May; 62(5):. PubMed ID: 29439979 [TBL] [Abstract][Full Text] [Related]
17. Multistage Antiplasmodium Activity of Astemizole Analogues and Inhibition of Hemozoin Formation as a Contributor to Their Mode of Action. Kumar M; Okombo J; Mambwe D; Taylor D; Lawrence N; Reader J; van der Watt M; Fontinha D; Sanches-Vaz M; Bezuidenhout BC; Lauterbach SB; Liebenberg D; Birkholtz LM; Coetzer TL; Prudêncio M; Egan TJ; Wittlin S; Chibale K ACS Infect Dis; 2019 Feb; 5(2):303-315. PubMed ID: 30525439 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and in silico ADME/Tox profiling studies of heterocyclic hybrids based on chloroquine scaffolds with potential antimalarial activity. Ramírez H; Fernandez-Moreira E; Rodrigues JR; Mijares MR; Ángel JE; Charris JE Parasitol Res; 2022 Jan; 121(1):441-451. PubMed ID: 34778907 [TBL] [Abstract][Full Text] [Related]
19. Standardization of the physicochemical parameters to assess in vitro the beta-hematin inhibitory activity of antimalarial drugs. Parapini S; Basilico N; Pasini E; Egan TJ; Olliaro P; Taramelli D; Monti D Exp Parasitol; 2000 Dec; 96(4):249-56. PubMed ID: 11162378 [TBL] [Abstract][Full Text] [Related]